The Department of Consumer Protection announced today that new preliminary data shows combined sales for adult-use cannabis and medical cannabis totaled nearly $23 million for the period from May 1, 2023, to May 31, 2023.
The adult-use market recorded $11.5 million in sales during the month of May, while the medical cannabis market recorded $11.2 million in sales for the same period. Adult-use sales began on January 10, 2023.
In May, medical cannabis patients purchased 312,758 products, and adult-use consumers purchased 292,054 products. The average product price for medical cannabis patients was $35.86 in May, while the average price of adult-use products was $39.47.
This data was collected through the state’s Seed-to-Sale Tracking System. DCP does not make revenue projections, set sales expectations, collect taxes, or regulate prices.
The preliminary data does not include taxes collected at the point of sale on adult-use transactions and is subject to further review by the department. Medical cannabis patients do not pay taxes on the purchase of their medicine.
Sales data for the medical cannabis market is not available prior to January 10, 2023. Seed-to-sale tracking was not previously required for medical cannabis sales. Adult-use and medical cannabis sales are now recorded in BioTrack, the inventory tracking system used to monitor the movement of cannabis in the state’s medical and adult-use cannabis markets.
Transaction limits of 1/4 ounce of raw flower or the equivalent remain in effect for all adult-use purchases. Medical cannabis patients may purchase up to 5 ounces per month and are not subject to individual transaction limits.
The department will make future data available at ct.gov/cannabis. The data will be updated monthly on or after the 10th of each month, and new data will continue to be added as it becomes available.